Brief: Allergy Therapeutics Sees H2 Revenue At £21.6M
22/07/2024 07:14
July 22 (Reuters) - Allergy Therapeutics PLC AGY.L :
* ALLERGY THERAPEUTICS - TRADING UPDATE FOR THE YEAR ENDED
30
JUNE 2024
* ALLERGY THERAPEUTICS PLC - H2 REVENUE EXPECTED AT £21.6M
Source text for Eikon: ID:nRSV1697Xa
Further company coverage: AGY.L
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Allergy Therapeutics
See all newsRCS - Allergy Therapeutics - Allergy Therapeutics to present at EAACI 2026
UK's Allergy Therapeutics H1 revenue rises 7%, operating loss widens
Brief: Allergy Therapeutics H1 Pretax Profit GBP -19.33 Million
Allergy Therapeutics - Interim Results for six months ended 31 Dec 2025
Allergy Therapeutics - PDMR Dealings & Shareholding Update